SAPHROXOL C75 Ambroxol Hydrochloride 75mg Extended-Release Capsule 1's
RXDRUG-DRP-6732-1pc
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications
Mucolytic. Used for Respiratory diseases and other conditions.
Administration
Administer with food.
Dosage
As slow-release (retard) cap: 75 mg once daily. Seek medical advice if symptoms persist for more than 14 days.
Storage
Store below 30°C. Protect from light.
Contraindications
Hypersensitivity to ambroxol or any component of the formulation. Refer to manufacturer labeling for further detail.
Common side-effects
Nausea, Vomiting, Gastrointestinal discomfort
MedsGo Class
Cough & Cold Preparations
Features
Brand
Saphroxol C75
Full Details
Dosage Strength
75 mg
Drug Ingredients
- Ambroxol
Drug Packaging
Extended-Release Capsule 1's
Generic Name
Ambroxol Hcl
Dosage Form
Extended-Release Capsule
Registration Number
DRP-6732
Drug Classification
Prescription Drug (RX)
View all variations as list
| CODE | Dosage Strength | Drug Packaging | Availability | Price | ||
|---|---|---|---|---|---|---|
|
RXDRUG-DRP-6732-1pc
|
In stock
|
₱1600 |
Please sign in so that we can notify you about a reply